GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Study Finds Long-Term Air Pollution Exposure Reduces Health Benefits of Regular Exercise

by GOAI
Share To

A recent study conducted by an international team of researchers, including experts from University College London (UCL), indicates that long-term exposure to air pollution may significantly diminish the health benefits associated with regular exercise. The findings suggest that toxic air pollutants can interfere with the positive effects of physical activity on overall health.

The research highlights how prolonged exposure to polluted air could counteract the advantages typically gained through consistent exercise, such as improved cardiovascular and respiratory health. The study underscores the potential risks posed by environmental factors, particularly in areas with high levels of air pollution. Researchers examined data linking air quality and physical activity to assess how pollution impacts the body’s response to exercise over time. These findings contribute to a growing body of evidence on the complex relationship between environmental conditions and public health outcomes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top